
Radio and PodcastLive Radio & Podcasts
Episode 211: Granulomatosis with Polyangiitis
Granulomatosis with Polyangiitis (GPA) – Recognition and Management in the ED Hosts: Phoebe Draper, MD Brian Gilberti, MD Download One Comment Tags: Rheumatology Show Notes Background A vasculitis affecting small blood v...
About This Episode
Episode 211: Granulomatosis with Polyangiitis is an episode from Core EM Podcast by Core EM. Granulomatosis with Polyangiitis (GPA) – Recognition and Management in the ED Hosts: Phoebe Draper, MD Brian Gilberti, MD Download One Comment Tags...
This episode belongs to Core EM Podcast.
Use the player on this page to stream the episode online.
Published Jul 1, 2025, audio available.
Questions About This Episode
What is Episode 211: Granulomatosis with Polyangiitis about?
Granulomatosis with Polyangiitis (GPA) – Recognition and Management in the ED Hosts: Phoebe Draper, MD Brian Gilberti, MD Download One Comment Tags: Rheumatology Show Notes Background A vasculitis affecting small blood vessels causing inflammation and necrosis Affects upper respiratory tract (sinusitis, otitis media, saddle nose deformity), lungs (nodules, alveolar hemorrhage), and kidneys (rapidly progressive glomerulonephritis) Can lead to multi-organ failure, pulmonary hemorrhage, renal failure Red Flag Symptoms: Chronic sinus symptoms Hemoptysis (especially bright red blood) New pulmonary complaints Renal dysfunction Constitutional symptoms (fatigue, weight loss, fever) Workup in the ED: CBC, CMP for anemia and AKI Urinalysis with microscopy (hematuria, RBC casts) Chest imaging (CXR or CT for nodules, cavitary lesions) ANCA testing (not immediately available but important diagnostically) Management: Stable patients: Outpatient workup, urgent rheumatology consult, prednisone 1 mg/kg/day Unstable patients: High-dose IV steroids (methylprednisolone 1 g daily x3 days), consider plasma exchange, cyclophosphamide or rituximab initiation, ICU admission Conditions that Mimic GPA: Goodpasture syndrome (anti-GBM antibodies) TB, fungal infections Lung malignancy Other vasculitides (EGPA, MPA, lupus) ANCA Testing Utility: C-ANCA/PR3-ANCA positive in 80-90% of GPA cases P-ANCA/MPO-ANCA more common in MPA Don’t delay treatment while awaiting results if suspicion is high Outcomes: Without treatment: Fatal within a year (renal failure, respiratory complications) With treatment: 5-year survival ~75-90%, but ~50% relapse rate Long-term rheumatology follow-up is essential Take-Home Points: Always include vasculitis in the differential for unexplained respiratory, renal, or systemic symptoms. Recognize pulmonary-renal syndromes early. Initiate high-dose steroids immediately for unstable patients without waiting for ANCA results. GPA is rare but life-threatening – early recognition saves lives. Read More
Where can I listen to Episode 211: Granulomatosis with Polyangiitis?
You can listen to Episode 211: Granulomatosis with Polyangiitis online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Episode 211: Granulomatosis with Polyangiitis from?
Episode 211: Granulomatosis with Polyangiitis is an episode from Core EM Podcast by Core EM.
How long is this episode?
The episode duration depends on the source podcast feed and may not always be available.
When was this episode published?
This episode was published on Jul 1, 2025.
Can I save Episode 211: Granulomatosis with Polyangiitis for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Core EM Podcast?
Yes. This page shows related episodes from Core EM Podcast when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Episode 211: Granulomatosis with Polyangiitis?
You can listen to Episode 211: Granulomatosis with Polyangiitis on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Episode 211: Granulomatosis with Polyangiitis is from Core EM Podcast by Core EM.
What are the episode details?
Published Jul 1, 2025






